HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hye Jin Jung Selected Research

Carrier Proteins (Binding Protein)

1/2018Downregulation of mitochondrial UQCRB inhibits cancer stem cell-like properties in glioblastoma.
10/2014Development of a novel class of mitochondrial ubiquinol-cytochrome c reductase binding protein (UQCRB) modulators as promising antiangiogenic leads.
9/2013Mitochondrial UQCRB regulates VEGFR2 signaling in endothelial cells.
2/2011Identification of a novel small molecule targeting UQCRB of mitochondrial complex III and its anti-angiogenic activity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hye Jin Jung Research Topics

Disease

32Neoplasms (Cancer)
03/2024 - 02/2007
20Hypoxia (Hypoxemia)
03/2021 - 04/2010
10Glioblastoma (Glioblastoma Multiforme)
01/2023 - 05/2015
5Stomach Neoplasms (Stomach Cancer)
03/2023 - 08/2018
3Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2021 - 08/2018
3Melanoma (Melanoma, Malignant)
04/2020 - 07/2016
2Leukemia
01/2024 - 04/2021
2Neoplasm Metastasis (Metastasis)
09/2023 - 10/2016
2Hepatocellular Carcinoma (Hepatoma)
10/2021 - 06/2020
2Brain Neoplasms (Brain Tumor)
01/2021 - 01/2018
2Carcinogenesis
02/2011 - 01/2010
2Corneal Neovascularization
12/2007 - 02/2007
1Multiple Myeloma
01/2024
1Hematologic Neoplasms (Hematological Malignancy)
01/2024
1Triple Negative Breast Neoplasms
09/2023
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2023
1Adenocarcinoma
03/2021
1Carcinoma (Carcinomatosis)
07/2020
1Inflammation (Inflammations)
03/2019
1Liver Neoplasms (Liver Cancer)
08/2018
1Tuberculosis (Tuberculoses)
07/2016

Drug/Important Bio-Agent (IBA)

13Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2021 - 08/2010
7Reactive Oxygen Species (Oxygen Radicals)IBA
04/2021 - 04/2010
5Angiogenesis InhibitorsIBA
01/2021 - 02/2011
4Carrier Proteins (Binding Protein)IBA
01/2018 - 02/2011
4Electron Transport Complex III (Coenzyme Q-Cytochrome-c Reductase)IBA
10/2014 - 04/2010
3Cyclophilin AIBA
05/2023 - 03/2021
3terpestacinIBA
01/2023 - 04/2010
2IntegrinsIBA
01/2024 - 09/2022
2Antineoplastic Agents (Antineoplastics)IBA
01/2023 - 01/2020
2berbamine (penduline)IBA
11/2022 - 01/2021
2STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
09/2022 - 10/2021
2Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA
03/2022 - 01/2019
2Caspase 3 (Caspase-3)IBA
04/2021 - 03/2019
2ampelopsinIBA
04/2021 - 12/2017
2alizarinIBA
07/2020 - 08/2018
2ResveratrolIBA
01/2020 - 07/2016
2Melanocyte-Stimulating Hormones (MSH)IBA
03/2019 - 07/2016
2GlucosidesIBA
08/2018 - 04/2015
2Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
01/2017 - 09/2015
2Proteins (Proteins, Gene)FDA Link
01/2017 - 02/2015
1furamidine (DB75)IBA
03/2024
1Natalizumab (Tysabri)FDA Link
01/2024
1Cysteine (L-Cysteine)FDA Link
01/2024
1Integrin alpha4beta1 (VLA-4)IBA
01/2024
1Monoclonal AntibodiesIBA
01/2024
1bufotalinIBA
09/2023
1Amino AcidsFDA Link
01/2023
11,4-dihydroxyanthraquinone (quinizarin)IBA
12/2022
1arcyriaflavin AIBA
11/2022
1Mevalonic Acid (Mevalonate)IBA
09/2022
1Phosphotransferases (Kinase)IBA
09/2022
1Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA
09/2022
1CateninsIBA
09/2022
1Aldehyde DehydrogenaseIBA
09/2022
1Sorafenib (BAY 43-9006)FDA Link
09/2022
1Atorvastatin (Lipitor)FDA Link
09/2022
1violaceinIBA
10/2021
1tamarixetinIBA
06/2021
1QuercetinIBA
06/2021
1Caspase 9IBA
04/2021
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
04/2021
1CyclinsIBA
04/2021
1Cyclin-Dependent Kinases (cdk Proteins)IBA
04/2021
1nargenicin A1IBA
03/2021
1CaspasesIBA
03/2021
1Chloroform (Trichloromethane)IBA
01/2021
1Therapeutic UsesIBA
01/2021
1Biomarkers (Surrogate Marker)IBA
01/2021
1mangostinIBA
06/2020
1GlycosidesIBA
06/2020
1Death Domain ReceptorsIBA
04/2020
1beauvericinIBA
04/2020
1pterostilbeneIBA
01/2020
1Peptides (Polypeptides)IBA
03/2019
1Bee Venoms (Bee Venom)IBA
03/2019
1Melanins (Melanin)IBA
03/2019
1Melitten (Melittin)IBA
03/2019
1Temozolomide (Temodar)FDA LinkGeneric
03/2019
1ImmunosorbentsIBA
03/2019
1EnzymesIBA
03/2019
1hydrazinobenzoylcurcuminIBA
01/2019
1CurcuminIBA
01/2019
1elaiophylinIBA
03/2018
1ubiquinolIBA
01/2018
1Oxidoreductases (Dehydrogenase)IBA
01/2018
120- O- (beta- D- glucopyranosyl)- 20(S)- protopanaxadiolIBA
08/2017
1ApigeninIBA
11/2016
1tricinIBA
10/2016
1InterferonsIBA
07/2016
1alpha-MSHIBA
07/2016
1Adenosine Monophosphate (AMP)IBA
07/2016
1flavoneIBA
07/2016
1Microphthalmia-Associated Transcription FactorIBA
07/2016
16,7-dihydroxyflavoneIBA
07/2016

Therapy/Procedure

10Therapeutics
01/2024 - 02/2011
3Drug Therapy (Chemotherapy)
04/2021 - 11/2016
2Radiotherapy
04/2021 - 11/2016
1Bone Marrow Transplantation (Transplantation, Bone Marrow)
04/2021
1Complementary Therapies (Alternative Medicine)
01/2021